Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock
F. M. Robertson, P. J. Offner, D. P. Ciceri, W. K. Becker and B. A. Pruitt Jr
Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, Tex.
OBJECTIVE: To investigate the physiologic effects of nitric oxide synthase
inhibition with N-nitro-L-arginine methyl ester in an acute resuscitated
model of porcine septic shock. DESIGN: Randomized control trial. SETTING:
Animal research facility. STUDY SUBJECTS: Domestic Yorkshire swine.
INTERVENTIONS: Twenty-four animals were randomly divided into one of four
treatment groups as follows: normal saline resuscitation (NSR) (control
group); NSR plus 200 micrograms/kg of lipopolysaccharide (LPS) at 1 hour
after baseline (LPS group); NSR, LPS, and a continuous infusion of 50
micrograms/kg per minute of N-nitro-L-arginine methyl ester (NAME) at 1
hour after baseline (LPS/NAME group); and NSR and NAME (NAME group). All
animals received NSR at 1 mL/kg per minute starting at baseline. MAIN
OUTCOME MEASURES: Mean arterial pressure (MAP), systemic vascular
resistance index (SVRI), mean pulmonary arterial pressure (MPAP), and
pulmonary vascular resistance index (PVRI) were measured at baseline and
hourly for 4 hours. Values at baseline and 3 hours are given below as mean
(+/- SE). RESULTS: All variables remained unchanged in the control group.
The administration of LPS produced a systemic hyperdynamic response
characterized by a decrease in MAP and SVRI from 66.0 +/- 3.9 to 55.0 +/-
2.8 mm Hg (P < .05) and from 422.0 +/- 22.0 to 272.0 +/- 29.0 mm
Hg.min.kg/L (P < .05), respectively. The administration of LPS produced
an increase in MPAP and PVRI from 16.3 +/- 0.8 to 30.0 +/- 1.3 mm Hg (P
< .05) and from 37.0 +/- 5.3 to 119.0 +/- 13.0 mm Hg.min.kg/L (P <
.05), respectively. In the LPS/NAME group, NAME infusion normalized MAP and
increased SVRI from 506.0 +/- 40.0 to 642.0 +/- 72.0 mm Hg.min.kg/L (P <
.05). Infusion of NAME potentiated LPS-induced pulmonary hypertension,
increasing MPAP and PVRI from 16.8 +/- 0.6 to 36.0 +/- 2.8 mm Hg (P <
.05) and from 59.0 +/- 3.5 to 319.0 +/- 64.0 mm Hg.min.kg/L (P < .05),
respectively. Infusion of NAME alone increased MAP from 74.0 +/- 1.3 to
100.0 +/- 4.1 mm Hg (P < .05) and had no significant effect on MPAP and
PVRI. CONCLUSIONS: The potentiation of LPS-induced pulmonary hypertension
following NAME infusion suggests that inhibition of nitric oxide synthase
may have a limited role in the treatment of septic shock.
Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility
Ehrentraut et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:2170-2176.
ABSTRACT
| FULL TEXT
Arginine Supplementation and Wound Healing
Stechmiller et al.
Nutr Clin Pract 2005;20:52-61.
ABSTRACT
| FULL TEXT
Modulation of endotoxin-induced cardiopulmonary dysfunction by S-nitroso-albumin
Gluckman et al.
Innate Immunity 2002;8:17-26.
ABSTRACT
Immunomodulation of Pneumococcal Pulmonary Infection with NG-Monomethyl-L-Arginine
Bergeron et al.
Antimicrob. Agents Chemother. 1999;43:2283-2290.
ABSTRACT
| FULL TEXT
Biphasic changes in left ventricular function during hyperdynamic endotoxemia
Ishihara et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999;276:R1516-R1524.
ABSTRACT
| FULL TEXT
Inhaled nitric oxide prevents left ventricular impairment during endotoxemia
Ishihara et al.
J. Appl. Physiol. 1998;85:2018-2024.
ABSTRACT
| FULL TEXT
Microvascular Endothelial Cell Control of Peripheral Vascular Resistance During Sepsis
Tucker et al.
Arch Surg 1998;133:1335-1342.
ABSTRACT
| FULL TEXT
Nitric Oxide Opposes Phorbol Ester-Induced Increases in Pulmonary Microvascular Permeability in Dogs
Sprague et al.
J. Pharmacol. Exp. Ther. 1998;284:443-448.
ABSTRACT
| FULL TEXT
Nitric Oxide Synthase Inhibition Restores Hypoxic Pulmonary Vasoconstriction in Sepsis
FISCHER et al.
Am. J. Respir. Crit. Care Med. 1997;156:833-839.
ABSTRACT
| FULL TEXT
Selective iNOS Inhibition Is Superior to Norepinephrine in the Treatment of Rat Endotoxic Shock
ROSSELET et al.
Am. J. Respir. Crit. Care Med. 1997;157:162-170.
ABSTRACT
| FULL TEXT
Nitric oxide contributes to desipramine- induced hypotension in rats
Pentel et al.
Hum Exp Toxicol 1996;15:320-328.
ABSTRACT